Experimental and clinical results with the Corynebacterium granulosum-derived immunomodulator P40.
D000276:Adjuvants, Immunologic / Q000302:isolation & purification / Q000627:therapeutic use*; D000818:Animals; D003352:Corynebacterium / Q000276:immunology*; D006801:Humans; D007109:Immunity; D007239:Infections / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000628:therapy; D051381:Rats
D000276:Adjuvants, Immunologic